Windtree Therapeutics (WINT) Short Interest Ratio & Short Volume $0.10 -0.01 (-5.02%) As of 03:58 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Windtree Therapeutics Short Interest DataWindtree Therapeutics (WINT) has a short interest of 1.79 million shares, representing 49.05% of the float (the number of shares available for trading by the public). This marks a -31.15% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 5.80 million shares to cover all short positions.Current Short Interest1,790,000 sharesPrevious Short Interest2,600,000 sharesChange Vs. Previous Month-31.15%Dollar Volume Sold Short$1.21 millionShort Interest Ratio0.2 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares3,661,000 sharesShort Percent of Float49.05%Today's Trading Volume746,389 sharesAverage Trading Volume5,795,643 sharesToday's Volume Vs. Average13% Short Selling Windtree Therapeutics? Sign up to receive the latest short interest report for Windtree Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartWINT Short Interest Over TimeWINT Days to Cover Over TimeWINT Percentage of Float Shorted Over Time Windtree Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20251,790,000 shares $1.21 million -31.2%49.1%0.2 $0.68 7/15/20252,600,000 shares $2.15 million +1,508.9%N/A0.3 $0.83 6/30/2025161,600 shares $83.40 thousand -82.6%4.4%1.2 $0.52 6/15/2025930,100 shares $550.62 thousand +411.0%25.5%0.3 $0.59 5/31/2025182,000 shares $142.52 thousand +70.4%24.3%0 $0.78 5/15/2025106,800 shares $88.64 thousand +110.2%14.3%0 $0.83 4/30/202550,800 shares $59.44 thousand -23.6%6.8%0 $1.17 4/15/202566,500 shares $78.47 thousand -76.2%8.9%0 $1.18 3/31/2025279,300 shares $351.92 thousand +466.5%37.3%0.1 $1.26 3/15/202549,300 shares $101.07 thousand -40.6%6.6%0 $2.05 Get the Latest News and Ratings for WINT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Windtree Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/28/202583,000 shares $263.94 thousand +44.9%11.1%0.3 $3.18 2/15/202557,300 shares $393.65 thousand -67.1%7.7%0.4 $6.87 1/31/2025174,100 shares $22.74 thousand -80.9%1.6%0 $0.13 1/15/2025909,000 shares $220.89 thousand +72.4%8.3%0.3 $0.24 12/31/2024527,200 shares $184.15 thousand +6.1%5.9%0.2 $0.35 12/15/2024497,000 shares $175.64 thousand +228.5%5.6%0.3 $0.35 11/30/2024151,300 shares $80.26 thousand +389.6%1.7%0.1 $0.53 11/15/202430,900 shares $14.68 thousand -84.2%0.4%0 $0.48 10/31/2024195,700 shares $137.66 thousand +301.9%2.4%0.1 $0.70 10/15/202448,700 shares $32.14 thousand -50.7%1.4%0 $0.66 9/30/202498,700 shares $235.89 thousand +174.9%2.8%0.1 $2.39 9/15/202435,900 shares $113.80 thousand -65.9%2.6%0 $3.17 8/31/2024105,400 shares $854.79 thousand -6.8%23.9%0.1 $8.11 8/15/2024113,100 shares $1.26 million -56.8%25.6%0.1 $11.14 7/31/2024261,700 shares $2.39 million +455.6%59.3%0.3 $9.12 7/15/202447,100 shares $174.27 thousand -17.5%10.7%1.5 $3.70 6/30/202457,100 shares $183.29 thousand +21.2%12.9%1.8 $3.21 6/15/202447,100 shares $146.01 thousand +20.8%10.7%1.7 $3.10 5/31/202439,000 shares $138.06 thousand +89.3%9.1%1.6 $3.54 5/15/202420,600 shares $94.78 thousand +62.2%4.8%0.8 $4.60 4/30/202412,700 shares $63.88 thousand +388.5%3.0%0.6 $5.03 4/15/20242,600 shares $19.66 thousand -93.5%N/A0.2 $7.56 3/31/202439,700 shares $14.05 thousand +30.2%0.5%0.2 $0.35 3/15/202430,500 shares $10.37 thousand -47.8%0.4%0.1 $0.34 2/29/202458,400 shares $21.02 thousand -42.2%0.8%0.2 $0.36 2/15/2024101,100 shares $36.09 thousand -56.0%1.9%0.3 $0.36 1/31/2024229,600 shares $96.50 thousand +353.8%5.3%0.8 $0.42 1/15/202450,600 shares $28.95 thousand +25.6%1.0%0.2 $0.57 12/31/202340,300 shares $28.98 thousand +108.8%N/A0.3 $0.72 12/15/202319,300 shares $14.09 thousand -55.5%0.5%0.2 $0.73What Are Some Strategies to Help Lower RMD Taxes? (Ad)Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain retirement accounts. Without the right strategy, these withdrawals can significantly increase your tax bill and shrink your nest egg. SmartAsset outlines six strategies that could help reduce your RMDs and potentially lower your tax burden. Their free tool can match you with vetted fiduciary financial advisors in your area—professionals legally bound to act in your best interest.Click here to see the six strategies and get your free advisor matches today. 11/30/202343,400 shares $50.34 thousand -13.4%1.1%0.4 $1.16 11/15/202350,100 shares $46.08 thousand -22.5%1.2%0.5 $0.92 10/31/202364,600 shares $67.83 thousand -65.8%1.5%0.5 $1.05 10/15/2023188,900 shares $236.13 thousand +540.3%4.3%1.5 $1.25 9/30/202329,500 shares $27.98 thousand +81.0%0.7%0.2 $0.95 9/15/202316,300 shares $18.75 thousand +27.3%0.4%0.1 $1.15 8/31/202312,800 shares $14.10 thousand -75.8%2.0%0.1 $1.10 8/15/202352,800 shares $85.54 thousand +294.0%7.9%0.2 $1.62 7/31/202313,400 shares $18.63 thousand +162.8%2.0%0 $1.39 7/15/20235,100 shares $6.83 thousand -42.1%N/A0 $1.34 6/30/20238,800 shares $11 thousand -90.5%N/A0 $1.25 6/15/202392,500 shares $142.45 thousand -2.9%N/A0.1 $1.54 5/31/202395,300 shares $121.98 thousand -51.2%N/A0.1 $1.28 5/15/2023195,100 shares $290.70 thousand +64.4%N/A0.2 $1.49 4/30/2023118,700 shares $194.67 thousand +136.9%68.7%0.1 $1.64 4/15/202350,100 shares $219.44 thousand +87.6%8.5%0.1 $4.38 3/31/202326,700 shares $133.23 thousand -2.9%4.7%0.2 $4.99 3/15/202327,500 shares $132.55 thousand -53.0%4.9%0.3 $4.82 2/28/202358,500 shares $367.38 thousand +604.8%10.3%0.6 $6.28 2/15/20238,300 shares $1.23 thousand -98.9%N/A0.1 $0.15 1/31/2023754,800 shares $120.77 thousand +16.1%N/A1.4 $0.16 1/15/2023650,300 shares $143.03 thousand -28.2%N/A1.3 $0.22 12/30/2022905,900 shares $154.00 thousand -28.7%N/A2 $0.17 12/15/20221,270,000 shares $226.06 thousand +4.1%N/A1.4 $0.18 11/30/20221,220,000 shares $234.85 thousand -3.2%N/A1.3 $0.19 11/15/20221,260,000 shares $110.25 thousand -9.4%5.3%1.2 $0.09 10/31/20221,390,000 shares $238.39 thousand -10.9%7.4%0.7 $0.17 10/15/20221,560,000 shares $379.70 thousand +26.8%8.3%0.8 $0.24 9/30/20221,230,000 shares $369.12 thousand +44.6%6.5%0.7 $0.30 9/15/2022850,900 shares $314.66 thousand -8.3%4.5%0.6 $0.37 8/31/2022928,000 shares $365.63 thousand +21.9%5.1%0.7 $0.39 8/15/2022761,500 shares $288.61 thousand +0.0%4.2%0.6 $0.38 7/31/2022761,200 shares $299.91 thousand -19.9%4.3%3.1 $0.39 7/15/2022950,700 shares $384.56 thousand +6.8%5.4%3.4 $0.40 6/30/2022890,200 shares $371.21 thousand +3.6%5.1%1.1 $0.42 6/15/2022858,900 shares $365.03 thousand -7.5%4.9%1.1 $0.43 5/31/2022928,500 shares $452.18 thousand +18.9%5.4%1.2 $0.49 5/15/2022781,200 shares $429.66 thousand -12.1%4.5%1.1 $0.55 4/30/2022888,700 shares $657.28 thousand +104.6%5.3%1.3 $0.74 4/15/2022434,400 shares $462.68 thousand -0.5%2.6%0.6 $1.07 3/31/2022436,400 shares $497.50 thousand -9.1%2.6%3.9 $1.14 3/15/2022480,100 shares $458.50 thousand +10.4%2.9%3.4 $0.96 2/28/2022434,800 shares $465.24 thousand -21.0%2.6%3.1 $1.07 2/15/2022550,600 shares $578.13 thousand +60.9%3.3%3.4 $1.05 1/31/2022342,200 shares $386.69 thousand -30.6%2.0%1.9 $1.13 1/15/2022493,000 shares $734.57 thousand +3.1%2.9%2.5 $1.49 12/31/2021478,000 shares $769.58 thousand -19.7%2.8%1.8 $1.61 12/15/2021595,400 shares $940.73 thousand -12.9%3.5%1.7 $1.58 11/30/2021683,600 shares $1.17 million -5.3%4.2%2 $1.71 11/15/2021721,900 shares $1.24 million -15.1%4.5%2 $1.72What Are Some Strategies to Help Lower RMD Taxes? (Ad)Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain retirement accounts. Without the right strategy, these withdrawals can significantly increase your tax bill and shrink your nest egg. SmartAsset outlines six strategies that could help reduce your RMDs and potentially lower your tax burden. Their free tool can match you with vetted fiduciary financial advisors in your area—professionals legally bound to act in your best interest.Click here to see the six strategies and get your free advisor matches today. 10/29/2021849,800 shares $1.51 million -21.3%5.6%2.2 $1.78 10/15/20211,080,000 shares $2.46 million +6.9%6.9%1.6 $2.28 9/30/20211,010,000 shares $2.08 million -18.6%6.5%1.6 $2.06 9/15/20211,240,000 shares $2.26 million -0.8%8.0%2.1 $1.82 8/31/20211,250,000 shares $2.45 million -27.3%8.1%1.8 $1.96 8/13/20211,720,000 shares $3.13 million +10.3%11.2%0.6 $1.82 7/30/20211,560,000 shares $2.95 million +1.3%19.8%0.5 $1.89 7/15/20211,540,000 shares $2.82 million -1.9%19.5%0.5 $1.83 6/30/20211,570,000 shares $3.60 million +6.1%19.9%0.5 $2.29 6/15/20211,480,000 shares $3.37 million +108.2%18.8%0.5 $2.28 5/28/2021710,900 shares $1.26 million +10.8%9.0%0.2 $1.77 5/14/2021641,500 shares $1.08 million +95.6%8.1%0.9 $1.68 4/30/2021328,000 shares $734.72 thousand +35.9%4.7%0.7 $2.24 4/15/2021241,400 shares $555.22 thousand +87.1%3.5%0.6 $2.30 3/31/2021129,000 shares $276.06 thousand -18.2%3.9%0.4 $2.14 3/15/2021157,600 shares $660.34 thousand +81.4%4.6%1 $4.19 2/26/202186,900 shares $438.41 thousand +1.6%2.5%1.8 $5.05 2/12/202185,500 shares $469.40 thousand -3.9%2.5%3.6 $5.49 1/29/202189,000 shares $501.07 thousand -0.8%2.6%5 $5.63 1/15/202189,700 shares $554.35 thousand No Change2.6%6.5 $6.18 WINT Short Interest - Frequently Asked Questions What is Windtree Therapeutics' current short interest? Short interest is the volume of Windtree Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 1,790,000 shares of WINT short. 49.05% of Windtree Therapeutics' shares are currently sold short. Learn More on Windtree Therapeutics' current short interest. What is a good short interest percentage for Windtree Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 49.05% of Windtree Therapeutics' floating shares are currently sold short. Is Windtree Therapeutics' short interest increasing or decreasing? Windtree Therapeutics saw a decline in short interest in July. As of July 31st, there was short interest totaling 1,790,000 shares, a decline of 31.2% from the previous total of 2,600,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Windtree Therapeutics' short interest compare to its competitors? 49.05% of Windtree Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Windtree Therapeutics: Aptorum Group Limited (5.63%), Artelo Biosciences, Inc. (2.57%), GENPREX (4.20%), Alzamend Neuro, Inc. (5.69%), Brainstorm Cell Therapeutics Inc. (4.93%), Sunshine Biopharma, Inc. (6.50%), Cardio Diagnostics Holdings, Inc. (1.18%), Apollomics Inc. (3.64%), Tharimmune, Inc. (0.29%), Nuvilex Inc. (0.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Windtree Therapeutics stock? Short selling WINT is an investing strategy that aims to generate trading profit from Windtree Therapeutics as its price is falling. WINT shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Windtree Therapeutics? A short squeeze for Windtree Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of WINT, which in turn drives the price of the stock up even further. How often is Windtree Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including WINT, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies APM Short Interest ARTL Short Interest GNPX Short Interest ALZN Short Interest BCLI Short Interest SBFM Short Interest CDIO Short Interest APLM Short Interest THAR Short Interest PMCB Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:WINT) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Windtree Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Windtree Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access